HEADER TRANSFERASE/TRANSFERASE INHIBITOR 31-JAN-17 5UNP TITLE STRUCTURE OF CDC2-LIKE KINASE 2 (CLK2) IN COMPLEX WITH COMPOUND T-025 TITLE 2 [N2-METHYL-N4-(PYRIMIDIN-2-YLMETHYL)-5-(QUINOLIN-6-YL)-7H-PYRROLO[2, TITLE 3 3-D]PYRIMIDINE-2,4-DIAMINE] COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE CLK2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CDC-LIKE KINASE 2; COMPND 5 EC: 2.7.12.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-GOLD(DE3)PLYSS AG KEYWDS PROTEIN KINASE, DUAL SPECIFICITY PROTEIN KINASE, INHIBITOR, KEYWDS 2 TRANSFERASE, COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.G.KLEIN,R.TJHEN REVDAT 2 06-MAR-24 5UNP 1 REMARK REVDAT 1 09-MAY-18 5UNP 0 JRNL AUTH K.IWAI,M.YAGUCHI,M.G.KLEIN JRNL TITL A NOVEL CLK INHIBITOR EXHIBITS ANTI-TUMOR EFFICACIES VIA JRNL TITL 2 MODULATING PRE-MRNA SPLICING AND TARGETING A MYC-DEPENDENT JRNL TITL 3 VULNERABILITY JRNL REF EMBO MOL MED 2018 JRNL REFN ESSN 1757-4684 REMARK 2 REMARK 2 RESOLUTION. 2.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0025 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 25181 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1333 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.92 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1850 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.95 REMARK 3 BIN R VALUE (WORKING SET) : 0.3470 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.3800 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5762 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 4 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 106.1 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.62000 REMARK 3 B22 (A**2) : -2.62000 REMARK 3 B33 (A**2) : 5.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.050 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.334 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.276 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.428 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5972 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 5544 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8068 ; 1.177 ; 1.950 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12706 ; 0.734 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 692 ; 5.838 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 320 ;33.191 ;22.938 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1038 ;14.975 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 56 ;18.324 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 840 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6754 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1508 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 137 483 B 137 483 22355 0.02 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5UNP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1000226179. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.977 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26725 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.920 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES (PH 7.0), 0.2M KBR, 0.2M REMARK 280 KSCN, 0.4-1.8% PGA (POLY-GAMA-GLUTAMIC ACID) AND 1-4% PEG MME REMARK 280 M.W. 2,000, PH 7.00, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y,Z REMARK 290 7555 -Y+1/2,X,Z+3/4 REMARK 290 8555 Y,-X+1/2,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 70.62600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 70.62600 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.18500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 70.62600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 31.09250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 70.62600 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 93.27750 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 70.62600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 70.62600 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 62.18500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 70.62600 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 93.27750 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 70.62600 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 31.09250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 ARG A 131 REMARK 465 SER A 132 REMARK 465 SER A 133 REMARK 465 SER A 134 REMARK 465 HIS A 135 REMARK 465 SER A 136 REMARK 465 ALA A 484 REMARK 465 GLU A 485 REMARK 465 PRO A 486 REMARK 465 PRO A 487 REMARK 465 ASN A 488 REMARK 465 LYS A 489 REMARK 465 LEU A 490 REMARK 465 TRP A 491 REMARK 465 ASP A 492 REMARK 465 SER A 493 REMARK 465 SER A 494 REMARK 465 ARG A 495 REMARK 465 ASP A 496 REMARK 465 GLY B 128 REMARK 465 GLY B 129 REMARK 465 SER B 130 REMARK 465 ARG B 131 REMARK 465 SER B 132 REMARK 465 SER B 133 REMARK 465 SER B 134 REMARK 465 HIS B 135 REMARK 465 SER B 136 REMARK 465 ALA B 484 REMARK 465 GLU B 485 REMARK 465 PRO B 486 REMARK 465 PRO B 487 REMARK 465 ASN B 488 REMARK 465 LYS B 489 REMARK 465 LEU B 490 REMARK 465 TRP B 491 REMARK 465 ASP B 492 REMARK 465 SER B 493 REMARK 465 SER B 494 REMARK 465 ARG B 495 REMARK 465 ASP B 496 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 310 CG CD OE1 OE2 REMARK 470 LYS A 412 CG CD CE NZ REMARK 470 GLU B 310 CG CD OE1 OE2 REMARK 470 LYS B 412 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 138 46.61 -93.00 REMARK 500 ASP A 145 53.98 -90.66 REMARK 500 ALA A 147 42.96 -73.27 REMARK 500 GLU A 148 104.00 -60.00 REMARK 500 ARG A 162 -46.03 -144.49 REMARK 500 LYS A 196 170.08 -50.56 REMARK 500 ASN A 197 73.18 -101.32 REMARK 500 ASP A 219 85.46 -151.40 REMARK 500 LEU A 225 2.72 85.06 REMARK 500 HIS A 236 17.25 54.82 REMARK 500 THR A 289 -17.45 84.64 REMARK 500 ASP A 290 42.08 -141.34 REMARK 500 LYS A 312 82.16 59.86 REMARK 500 ARG A 313 170.08 177.68 REMARK 500 SER A 317 112.36 -165.13 REMARK 500 ASP A 327 97.67 67.80 REMARK 500 VAL A 342 -43.69 -133.92 REMARK 500 ARG A 345 -56.38 -27.60 REMARK 500 SER A 359 -153.26 -171.51 REMARK 500 HIS A 384 31.99 -140.84 REMARK 500 THR A 443 -73.11 -85.09 REMARK 500 LEU A 482 -139.24 -99.98 REMARK 500 ARG B 138 46.77 -93.06 REMARK 500 ASP B 145 53.49 -90.69 REMARK 500 ALA B 147 43.55 -73.85 REMARK 500 GLU B 148 103.96 -58.35 REMARK 500 ARG B 162 -45.84 -144.47 REMARK 500 LYS B 196 170.21 -50.55 REMARK 500 ASN B 197 73.00 -101.46 REMARK 500 ASP B 219 85.58 -151.22 REMARK 500 LEU B 225 3.48 84.46 REMARK 500 HIS B 236 17.17 55.05 REMARK 500 THR B 289 -17.97 84.20 REMARK 500 ASP B 290 42.32 -141.06 REMARK 500 LYS B 312 81.95 59.90 REMARK 500 ARG B 313 170.14 177.73 REMARK 500 SER B 317 112.52 -164.92 REMARK 500 ASP B 327 97.63 68.10 REMARK 500 VAL B 342 -43.85 -133.77 REMARK 500 ARG B 345 -56.06 -27.87 REMARK 500 SER B 359 -153.01 -171.81 REMARK 500 HIS B 384 32.18 -140.99 REMARK 500 THR B 443 -73.23 -84.88 REMARK 500 LEU B 482 -138.94 -99.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8FY A 2501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8FY B 2501 DBREF 5UNP A 130 496 UNP P49760 CLK2_HUMAN 129 495 DBREF 5UNP B 130 496 UNP P49760 CLK2_HUMAN 129 495 SEQADV 5UNP GLY A 128 UNP P49760 EXPRESSION TAG SEQADV 5UNP GLY A 129 UNP P49760 EXPRESSION TAG SEQADV 5UNP GLY B 128 UNP P49760 EXPRESSION TAG SEQADV 5UNP GLY B 129 UNP P49760 EXPRESSION TAG SEQRES 1 A 369 GLY GLY SER ARG SER SER SER HIS SER SER ARG ARG ALA SEQRES 2 A 369 LYS SER VAL GLU ASP ASP ALA GLU GLY HIS LEU ILE TYR SEQRES 3 A 369 HIS VAL GLY ASP TRP LEU GLN GLU ARG TYR GLU ILE VAL SEQRES 4 A 369 SER THR LEU GLY GLU GLY THR PHE GLY ARG VAL VAL GLN SEQRES 5 A 369 CYS VAL ASP HIS ARG ARG GLY GLY ALA ARG VAL ALA LEU SEQRES 6 A 369 LYS ILE ILE LYS ASN VAL GLU LYS TYR LYS GLU ALA ALA SEQRES 7 A 369 ARG LEU GLU ILE ASN VAL LEU GLU LYS ILE ASN GLU LYS SEQRES 8 A 369 ASP PRO ASP ASN LYS ASN LEU CYS VAL GLN MET PHE ASP SEQRES 9 A 369 TRP PHE ASP TYR HIS GLY HIS MET CYS ILE SER PHE GLU SEQRES 10 A 369 LEU LEU GLY LEU SER THR PHE ASP PHE LEU LYS ASP ASN SEQRES 11 A 369 ASN TYR LEU PRO TYR PRO ILE HIS GLN VAL ARG HIS MET SEQRES 12 A 369 ALA PHE GLN LEU CYS GLN ALA VAL LYS PHE LEU HIS ASP SEQRES 13 A 369 ASN LYS LEU THR HIS THR ASP LEU LYS PRO GLU ASN ILE SEQRES 14 A 369 LEU PHE VAL ASN SER ASP TYR GLU LEU THR TYR ASN LEU SEQRES 15 A 369 GLU LYS LYS ARG ASP GLU ARG SER VAL LYS SER THR ALA SEQRES 16 A 369 VAL ARG VAL VAL ASP PHE GLY SER ALA THR PHE ASP HIS SEQRES 17 A 369 GLU HIS HIS SER THR ILE VAL SER THR ARG HIS TYR ARG SEQRES 18 A 369 ALA PRO GLU VAL ILE LEU GLU LEU GLY TRP SER GLN PRO SEQRES 19 A 369 CYS ASP VAL TRP SER ILE GLY CYS ILE ILE PHE GLU TYR SEQRES 20 A 369 TYR VAL GLY PHE THR LEU PHE GLN THR HIS ASP ASN ARG SEQRES 21 A 369 GLU HIS LEU ALA MET MET GLU ARG ILE LEU GLY PRO ILE SEQRES 22 A 369 PRO SER ARG MET ILE ARG LYS THR ARG LYS GLN LYS TYR SEQRES 23 A 369 PHE TYR ARG GLY ARG LEU ASP TRP ASP GLU ASN THR SER SEQRES 24 A 369 ALA GLY ARG TYR VAL ARG GLU ASN CYS LYS PRO LEU ARG SEQRES 25 A 369 ARG TYR LEU THR SER GLU ALA GLU GLU HIS HIS GLN LEU SEQRES 26 A 369 PHE ASP LEU ILE GLU SER MET LEU GLU TYR GLU PRO ALA SEQRES 27 A 369 LYS ARG LEU THR LEU GLY GLU ALA LEU GLN HIS PRO PHE SEQRES 28 A 369 PHE ALA ARG LEU ARG ALA GLU PRO PRO ASN LYS LEU TRP SEQRES 29 A 369 ASP SER SER ARG ASP SEQRES 1 B 369 GLY GLY SER ARG SER SER SER HIS SER SER ARG ARG ALA SEQRES 2 B 369 LYS SER VAL GLU ASP ASP ALA GLU GLY HIS LEU ILE TYR SEQRES 3 B 369 HIS VAL GLY ASP TRP LEU GLN GLU ARG TYR GLU ILE VAL SEQRES 4 B 369 SER THR LEU GLY GLU GLY THR PHE GLY ARG VAL VAL GLN SEQRES 5 B 369 CYS VAL ASP HIS ARG ARG GLY GLY ALA ARG VAL ALA LEU SEQRES 6 B 369 LYS ILE ILE LYS ASN VAL GLU LYS TYR LYS GLU ALA ALA SEQRES 7 B 369 ARG LEU GLU ILE ASN VAL LEU GLU LYS ILE ASN GLU LYS SEQRES 8 B 369 ASP PRO ASP ASN LYS ASN LEU CYS VAL GLN MET PHE ASP SEQRES 9 B 369 TRP PHE ASP TYR HIS GLY HIS MET CYS ILE SER PHE GLU SEQRES 10 B 369 LEU LEU GLY LEU SER THR PHE ASP PHE LEU LYS ASP ASN SEQRES 11 B 369 ASN TYR LEU PRO TYR PRO ILE HIS GLN VAL ARG HIS MET SEQRES 12 B 369 ALA PHE GLN LEU CYS GLN ALA VAL LYS PHE LEU HIS ASP SEQRES 13 B 369 ASN LYS LEU THR HIS THR ASP LEU LYS PRO GLU ASN ILE SEQRES 14 B 369 LEU PHE VAL ASN SER ASP TYR GLU LEU THR TYR ASN LEU SEQRES 15 B 369 GLU LYS LYS ARG ASP GLU ARG SER VAL LYS SER THR ALA SEQRES 16 B 369 VAL ARG VAL VAL ASP PHE GLY SER ALA THR PHE ASP HIS SEQRES 17 B 369 GLU HIS HIS SER THR ILE VAL SER THR ARG HIS TYR ARG SEQRES 18 B 369 ALA PRO GLU VAL ILE LEU GLU LEU GLY TRP SER GLN PRO SEQRES 19 B 369 CYS ASP VAL TRP SER ILE GLY CYS ILE ILE PHE GLU TYR SEQRES 20 B 369 TYR VAL GLY PHE THR LEU PHE GLN THR HIS ASP ASN ARG SEQRES 21 B 369 GLU HIS LEU ALA MET MET GLU ARG ILE LEU GLY PRO ILE SEQRES 22 B 369 PRO SER ARG MET ILE ARG LYS THR ARG LYS GLN LYS TYR SEQRES 23 B 369 PHE TYR ARG GLY ARG LEU ASP TRP ASP GLU ASN THR SER SEQRES 24 B 369 ALA GLY ARG TYR VAL ARG GLU ASN CYS LYS PRO LEU ARG SEQRES 25 B 369 ARG TYR LEU THR SER GLU ALA GLU GLU HIS HIS GLN LEU SEQRES 26 B 369 PHE ASP LEU ILE GLU SER MET LEU GLU TYR GLU PRO ALA SEQRES 27 B 369 LYS ARG LEU THR LEU GLY GLU ALA LEU GLN HIS PRO PHE SEQRES 28 B 369 PHE ALA ARG LEU ARG ALA GLU PRO PRO ASN LYS LEU TRP SEQRES 29 B 369 ASP SER SER ARG ASP HET 8FY A2501 29 HET 8FY B2501 29 HETNAM 8FY N~2~-METHYL-N~4~-[(PYRIMIDIN-2-YL)METHYL]-5-(QUINOLIN- HETNAM 2 8FY 6-YL)-7H-PYRROLO[2,3-D]PYRIMIDINE-2,4-DIAMINE FORMUL 3 8FY 2(C21 H18 N8) FORMUL 5 HOH *4(H2 O) HELIX 1 AA1 ARG A 184 GLY A 186 5 3 HELIX 2 AA2 VAL A 198 ASP A 219 1 22 HELIX 3 AA3 SER A 249 ASP A 256 1 8 HELIX 4 AA4 PRO A 263 ASN A 284 1 22 HELIX 5 AA5 LYS A 292 GLU A 294 5 3 HELIX 6 AA6 THR A 344 ARG A 348 5 5 HELIX 7 AA7 ALA A 349 LEU A 354 1 6 HELIX 8 AA8 SER A 359 GLY A 377 1 19 HELIX 9 AA9 ASP A 385 GLY A 398 1 14 HELIX 10 AB1 PRO A 401 THR A 408 1 8 HELIX 11 AB2 LYS A 410 LYS A 412 5 3 HELIX 12 AB3 THR A 425 CYS A 435 1 11 HELIX 13 AB4 PRO A 437 LEU A 442 5 6 HELIX 14 AB5 ALA A 446 LEU A 460 1 15 HELIX 15 AB6 THR A 469 GLN A 475 1 7 HELIX 16 AB7 HIS A 476 ALA A 480 5 5 HELIX 17 AB8 ARG B 184 GLY B 186 5 3 HELIX 18 AB9 VAL B 198 ASP B 219 1 22 HELIX 19 AC1 SER B 249 ASP B 256 1 8 HELIX 20 AC2 PRO B 263 ASN B 284 1 22 HELIX 21 AC3 LYS B 292 GLU B 294 5 3 HELIX 22 AC4 THR B 344 ARG B 348 5 5 HELIX 23 AC5 ALA B 349 LEU B 354 1 6 HELIX 24 AC6 SER B 359 GLY B 377 1 19 HELIX 25 AC7 ASP B 385 GLY B 398 1 14 HELIX 26 AC8 PRO B 401 THR B 408 1 8 HELIX 27 AC9 LYS B 410 LYS B 412 5 3 HELIX 28 AD1 THR B 425 CYS B 435 1 11 HELIX 29 AD2 PRO B 437 LEU B 442 5 6 HELIX 30 AD3 ALA B 446 LEU B 460 1 15 HELIX 31 AD4 THR B 469 GLN B 475 1 7 HELIX 32 AD5 HIS B 476 ARG B 481 1 6 SHEET 1 AA1 6 TRP A 158 LEU A 159 0 SHEET 2 AA1 6 TYR A 163 GLU A 171 -1 O TYR A 163 N LEU A 159 SHEET 3 AA1 6 GLY A 175 ASP A 182 -1 O GLN A 179 N VAL A 166 SHEET 4 AA1 6 ARG A 189 ILE A 195 -1 O ILE A 194 N ARG A 176 SHEET 5 AA1 6 HIS A 238 GLU A 244 -1 O PHE A 243 N ALA A 191 SHEET 6 AA1 6 MET A 229 TYR A 235 -1 N PHE A 230 O SER A 242 SHEET 1 AA2 2 LEU A 286 THR A 287 0 SHEET 2 AA2 2 THR A 332 PHE A 333 -1 O THR A 332 N THR A 287 SHEET 1 AA3 2 ILE A 296 PHE A 298 0 SHEET 2 AA3 2 VAL A 323 VAL A 325 -1 O ARG A 324 N LEU A 297 SHEET 1 AA4 2 TYR A 303 ASN A 308 0 SHEET 2 AA4 2 ARG A 313 VAL A 318 -1 O ARG A 313 N ASN A 308 SHEET 1 AA5 2 PHE A 414 TYR A 415 0 SHEET 2 AA5 2 ARG A 418 LEU A 419 -1 O ARG A 418 N TYR A 415 SHEET 1 AA6 6 TRP B 158 LEU B 159 0 SHEET 2 AA6 6 TYR B 163 GLU B 171 -1 O TYR B 163 N LEU B 159 SHEET 3 AA6 6 GLY B 175 ASP B 182 -1 O GLN B 179 N VAL B 166 SHEET 4 AA6 6 ARG B 189 ILE B 195 -1 O ILE B 194 N ARG B 176 SHEET 5 AA6 6 HIS B 238 GLU B 244 -1 O PHE B 243 N ALA B 191 SHEET 6 AA6 6 MET B 229 TYR B 235 -1 N PHE B 230 O SER B 242 SHEET 1 AA7 2 LEU B 286 THR B 287 0 SHEET 2 AA7 2 THR B 332 PHE B 333 -1 O THR B 332 N THR B 287 SHEET 1 AA8 2 ILE B 296 PHE B 298 0 SHEET 2 AA8 2 VAL B 323 VAL B 325 -1 O ARG B 324 N LEU B 297 SHEET 1 AA9 2 TYR B 303 ASN B 308 0 SHEET 2 AA9 2 ARG B 313 VAL B 318 -1 O ARG B 313 N ASN B 308 SHEET 1 AB1 2 PHE B 414 TYR B 415 0 SHEET 2 AB1 2 ARG B 418 LEU B 419 -1 O ARG B 418 N TYR B 415 SITE 1 AC1 13 LEU A 169 GLY A 170 GLU A 171 VAL A 177 SITE 2 AC1 13 LYS A 193 PHE A 243 GLU A 244 LEU A 246 SITE 3 AC1 13 GLY A 247 ASN A 295 LEU A 297 VAL A 326 SITE 4 AC1 13 ASP A 327 SITE 1 AC2 13 LEU B 169 GLY B 170 GLU B 171 VAL B 177 SITE 2 AC2 13 LYS B 193 PHE B 243 GLU B 244 LEU B 246 SITE 3 AC2 13 GLY B 247 ASN B 295 LEU B 297 VAL B 326 SITE 4 AC2 13 ASP B 327 CRYST1 141.252 141.252 124.370 90.00 90.00 90.00 I 41 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007080 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007080 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008041 0.00000